Table 1 .
Mean baseline characteristics and differences in blood pressure at follow-up between randomised groups in subgroups of younger and older adults
| Treatment comparison | Age <65 (n=96 466) | Age ≥65 (n=94 140) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total No | Age (years) | Baseline SBP/DBP (mm Hg) | Difference in SBP/DBP (mm Hg) | % Men | Total No | Age (years) | Baseline SBP/DBP (mm Hg) | Difference in SBP/DBP (mm Hg) | % Men | ||
| ACE-I v placebo | 19 154 | 57 | 137/82 | −4.6/−2.1 | 79 | 15 923 | 70 | 143/80 | −4.2/−2.0 | 72 | |
| CA v placebo | 2 597 | 58 | 149/83 | −7.2/−2.9 | 60 | 4354 | 72 | 168/84 | −9.3/−3.8 | 37 | |
| More v less* | 15 335 | 57 | 165/104 | −4.3/−3.5 | 57 | 6647 | 70 | 173/104 | −3.5/−3.4 | 47 | |
| ARB v other | 1464 | 56 | 151/85 | −1.7/−0.3 | 64 | 6338 | 75 | 163/89 | −2.0/−1.2 | 39 | |
| ACE-I v D/BB | 22 088 | 55 | 153/93 | 1.3/0.2 | 54 | 25 342 | 73 | 161/88 | 2.0/0.5 | 49 | |
| CA v D/BB | 43 594 | 58 | 154/93 | 1.1/−0.2 | 50 | 46 185 | 72 | 157/87 | 0.5/−0.4 | 46 | |
| ACE-I v CA | 10 049 | 59 | 145/87 | 0.9/0.6 | 55 | 16 310 | 73 | 160/87 | 1.0/1.0 | 49 | |
SBP/DBP=systolic/diastolic blood pressure; ACE-I=angiotensin converting enzyme inhibitor; CA=calcium antagonist; ARB=angiotensin receptor blocker; D/BB=diuretic or β blocker.
*More v less intensive blood pressure lowering regimen.